Clinical Trials Directory

Trials / Unknown

UnknownNCT01554787

Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Astragalus Membranaceus in the Patients After Stroke With Fatigue

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
China Medical University Hospital · Academic / Other
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The high levels of fatigue in stroke patients without neurological impairment suggest it has a central origin rather than being the result of increased physical effort required after stroke(Winward et al., 2009). Fatigue is different from post-stroke depression and the more serious stroke patients are more prone to fatigue(Windward et al., 2009). Fatigue is one of the symptoms of qi deficiency,and Astragalus membranaceus is the most effective of all traditional Chinese medicine and can tonifying middle and tonify the original qi. Therefore, the aim of this study was to investigate the efficacy of Astragalus membranaceus on post-stroke fatigue.

Conditions

Interventions

TypeNameDescription
DRUGChinese Herb Astragalus membranaceusAstragalus membranaceus(AM)at a rate of 2.8g three times per day
OTHERPlaceboat a rate of 2.8g three times per day

Timeline

Start date
2012-01-01
Primary completion
2013-12-01
First posted
2012-03-15
Last updated
2012-03-15

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT01554787. Inclusion in this directory is not an endorsement.